Poor sleep quality is associated with symptom severity in schizophrenia, including later illness onset, independent of chronotype or BDNF Val66Met variant.
Key Findings
Results
Poor sleep quality was highly prevalent in schizophrenia, affecting over two-thirds of patients.
69.12% of the 217 individuals with schizophrenia were classified as poor sleepers based on the Pittsburgh Sleep Quality Index (PSQI).
The study used a cross-sectional design with 217 participants assessed for sleep quality, chronotype, and symptom severity.
Sleep quality was measured using the Pittsburgh Sleep Quality Index.
Results
Poor sleep quality was significantly associated with greater symptom severity across all PANSS domains.
Poor sleep quality was significantly associated with PANSS total scores (β = 0.35, P < 0.001).
Significant associations were found for PANSS positive symptoms (β = 0.24, P < 0.001), negative symptoms (β = 0.27, P < 0.001), and general psychopathology (β = 0.31, P < 0.001).
These associations were determined via multivariate regression adjusting for covariates.
Symptom severity was measured using the Positive and Negative Syndrome Scale (PANSS).
Results
Schizophrenia patients with poor sleep quality had a later age of illness onset.
Patients with poor sleep quality had significantly later illness onset compared to good sleepers (P = 0.02).
This association was observed independent of chronotype or BDNF Val66Met genotype.
The finding was identified in the cross-sectional sample of 217 individuals with schizophrenia.
Results
Morning chronotype was associated with longer illness duration but lower general psychopathology scores.
Morning chronotype was significantly associated with longer illness duration (P = 0.03).
Morning chronotype was associated with lower general psychopathology scores on the PANSS (P = 0.02).
Chronotype was assessed using the Morningness-Eveningness Questionnaire (MEQ).
Chronotype did not moderate the relationship between sleep quality and symptom severity.
Results
The BDNF Val66Met genetic variant showed no association with sleep quality, chronotype, or symptom severity.
BDNF Val66Met showed no association with sleep quality, chronotype, or symptom severity in multivariate analyses.
The Val66Met variant did not moderate the relationship between sleep quality and symptom severity.
All 217 participants were genotyped for BDNF Val66Met.
These null findings held after adjustment for covariates in multivariate regression models.
Results
Plasma BDNF levels were higher in poor sleepers, independent of Val66Met genotype.
Poor sleepers had significantly higher plasma BDNF levels compared to good sleepers (P < 0.001, r = 0.65).
The large effect size (r = 0.65) indicates a strong association between plasma BDNF levels and sleep quality.
Plasma BDNF levels were measured in a subset of 91 patients.
This association was independent of the BDNF Val66Met genotype.
Results
The association between poor sleep quality and symptom severity in schizophrenia is independent of both chronotype and BDNF Val66Met genotype.
Multivariate regression models adjusted for chronotype, Val66Met genotype, and other covariates still showed significant sleep quality-symptom severity associations.
Neither chronotype nor BDNF Val66Met acted as a moderator of the sleep quality-symptom severity relationship.
The study design was cross-sectional with n = 217 participants.
The authors note that prior findings in this area have been inconsistent, potentially reflecting unmeasured biological moderators.
What This Means
This research suggests that poor sleep quality is extremely common among people with schizophrenia—nearly 70% of the 217 patients studied were classified as poor sleepers—and that sleeping poorly is strongly linked to worse psychiatric symptoms across all symptom domains, including positive symptoms (like hallucinations and delusions), negative symptoms (like social withdrawal), and general psychopathology. Patients with poor sleep also tended to develop schizophrenia later in life. These findings held up even after accounting for whether patients were naturally 'morning' or 'evening' types and for a specific gene variant (BDNF Val66Met) that has been thought to influence both sleep and brain health.
Interestingly, while a specific genetic variant (BDNF Val66Met) did not appear to affect sleep or symptoms, the actual measured protein levels of BDNF in the blood were significantly higher in poor sleepers, with a strong correlation. This suggests that while the inherited genetic variant may not matter much, the biological activity of BDNF itself may still play a role in sleep disturbances in schizophrenia. Patients with a morning chronotype tended to have been ill longer but had milder general symptoms, suggesting that body clock preferences may relate to illness course in complex ways.
This research suggests that sleep quality is an important and somewhat independent factor in the severity of schizophrenia symptoms, and that improving sleep could be a meaningful treatment target regardless of a patient's genetic background or natural sleep-wake preferences. The strong relationship between poor sleep and worse symptoms across all symptom domains highlights the potential value of routinely assessing and addressing sleep problems in people living with schizophrenia.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Kumar A, Shaju A, Sidharthan M, John J, Mundedath R, Haridas N, et al.. (2026). Poor sleep quality is associated with symptom severity in schizophrenia, independent of chronotype and BDNF Val66Met genetic variant.. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2026.111907